From the findings obtained, we have proposed a model for how Yip1A functions as a prosurvival modulator that coordinately activates the IRE1 and PERK pathways of the UPR to support the survival of HeLa and CaSki cervical cancer cells (Figure 7). This evidence concerns the gene ERN1 and cervical cancer.